139 related articles for article (PubMed ID: 35733389)
1. Targeting the adrenomedullin-2 receptor for the discovery and development of novel anti-cancer agents.
Jailani ABA; Bigos KJA; Avgoustou P; Egan JL; Hathway RA; Skerry TM; Richards GO
Expert Opin Drug Discov; 2022 Aug; 17(8):839-848. PubMed ID: 35733389
[TBL] [Abstract][Full Text] [Related]
2. Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties.
Watkins HA; Chakravarthy M; Abhayawardana RS; Gingell JJ; Garelja M; Pardamwar M; McElhinney JM; Lathbridge A; Constantine A; Harris PW; Yuen TY; Brimble MA; Barwell J; Poyner DR; Woolley MJ; Conner AC; Pioszak AA; Reynolds CA; Hay DL
J Biol Chem; 2016 May; 291(22):11657-75. PubMed ID: 27013657
[TBL] [Abstract][Full Text] [Related]
3. Shared and separate functions of the RAMP-based adrenomedullin receptors.
Kuwasako K; Kitamura K; Nagata S; Hikosaka T; Takei Y; Kato J
Peptides; 2011 Jul; 32(7):1540-50. PubMed ID: 21645567
[TBL] [Abstract][Full Text] [Related]
4. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
Watkins HA; Walker CS; Ly KN; Bailey RJ; Barwell J; Poyner DR; Hay DL
Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
[TBL] [Abstract][Full Text] [Related]
5. Expression of adrenomedullin in human colorectal tumors and its role in cell growth and invasion in vitro and in xenograft growth in vivo.
Nouguerède E; Berenguer C; Garcia S; Bennani B; Delfino C; Nanni I; Dahan L; Gasmi M; Seitz JF; Martin PM; Ouafik L
Cancer Med; 2013 Apr; 2(2):196-207. PubMed ID: 23634287
[TBL] [Abstract][Full Text] [Related]
6. Bacterial expression and purification of a heterodimeric adrenomedullin receptor extracellular domain complex using DsbC-assisted disulfide shuffling.
Hill HE; Pioszak AA
Protein Expr Purif; 2013 Mar; 88(1):107-13. PubMed ID: 23247088
[TBL] [Abstract][Full Text] [Related]
7. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
[TBL] [Abstract][Full Text] [Related]
8. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
[TBL] [Abstract][Full Text] [Related]
9. Novel function for receptor activity-modifying proteins (RAMPs) in post-endocytic receptor trafficking.
Bomberger JM; Parameswaran N; Hall CS; Aiyar N; Spielman WS
J Biol Chem; 2005 Mar; 280(10):9297-307. PubMed ID: 15613468
[TBL] [Abstract][Full Text] [Related]
10. Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.
Woolley MJ; Reynolds CA; Simms J; Walker CS; Mobarec JC; Garelja ML; Conner AC; Poyner DR; Hay DL
Biochem Pharmacol; 2017 Oct; 142():96-110. PubMed ID: 28705698
[TBL] [Abstract][Full Text] [Related]
11. Adrenomedullin stimulates proliferation and inhibits apoptosis of immature rat thymocytes cultured in vitro.
Belloni AS; Trejter M; Malendowicz LK; Nussdorfer GG
Peptides; 2003 Feb; 24(2):295-300. PubMed ID: 12668215
[TBL] [Abstract][Full Text] [Related]
12. Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.
Moad HE; Pioszak AA
Protein Sci; 2013 Dec; 22(12):1775-85. PubMed ID: 24115156
[TBL] [Abstract][Full Text] [Related]
13. Structure and Dynamics of Adrenomedullin Receptors AM
Liang YL; Belousoff MJ; Fletcher MM; Zhang X; Khoshouei M; Deganutti G; Koole C; Furness SGB; Miller LJ; Hay DL; Christopoulos A; Reynolds CA; Danev R; Wootten D; Sexton PM
ACS Pharmacol Transl Sci; 2020 Apr; 3(2):263-284. PubMed ID: 32296767
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the single transmembrane domain of human receptor activity-modifying protein 3 in adrenomedullin receptor internalization.
Kuwasako K; Kitamura K; Nagata S; Nozaki N; Kato J
Biochem Biophys Res Commun; 2012 Apr; 420(3):582-7. PubMed ID: 22445753
[TBL] [Abstract][Full Text] [Related]
15. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
[TBL] [Abstract][Full Text] [Related]
16. Altered gene expression of adrenomedullin and its receptor system and molecular forms of tissue adrenomedullin in left ventricular hypertrophy induced by malignant hypertension.
Tadokoro K; Nishikimi T; Mori Y; Wang X; Akimoto K; Matsuoka H
Regul Pept; 2003 Apr; 112(1-3):71-8. PubMed ID: 12667627
[TBL] [Abstract][Full Text] [Related]
17. Regulation of adrenomedullin signaling in kidney interstitial fibroblasts.
Parameswaran N; Hall CC; Bomberger JM; Spielman WS
Cell Physiol Biochem; 2003; 13(6):391-400. PubMed ID: 14631146
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a First-in-Class Potent Small Molecule Antagonist against the Adrenomedullin-2 Receptor.
Avgoustou P; Jailani ABA; Zirimwabagabo JO; Tozer MJ; Gibson KR; Glossop PA; Mills JEJ; Porter RA; Blaney P; Bungay PJ; Wang N; Shaw AP; Bigos KJA; Holmes JL; Warrington JI; Skerry TM; Harrity JPA; Richards GO
ACS Pharmacol Transl Sci; 2020 Aug; 3(4):706-719. PubMed ID: 32832872
[TBL] [Abstract][Full Text] [Related]
20. Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma.
Deville JL; Bartoli C; Berenguer C; Fernandez-Sauze S; Kaafarani I; Delfino C; Fina F; Salas S; Muracciole X; Mancini J; Lechevallier E; Martin PM; Figarella-Branger D; Ouafik L; Daniel L
Int J Cancer; 2009 Nov; 125(10):2307-15. PubMed ID: 19610056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
